Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/27383
Title: Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı.
0000-0002-8974-8837
Şentürk, Tunay
Tütüncü, Ahmet
Özdemir, Bülent
Özdabakoğlu, Osman
Aydın, Sami
Baran, İbrahim
Güllülü, Sümeyye
Savcı, Vahide
Aydınlar, Ali
AAI-6632-2021
C-1517-2017
8342098300
7004229025
7004168959
25221805700
7005387015
35572557400
57204660708
6603687024
6603131517
Keywords: Acute coronary syndrome
Choline
Coronary artery disease
Stable angina pectoris
Whole-blood choline
Phospholipase-D
Plaque vulnerability
Atherosclerosis
Macrophages
Biomarkers
Activation
Mechanisms
Ischemia
Cardiovascular system & cardiology
Issue Date: Dec-2010
Publisher: Lippincott Williams & Wilkins
Citation: Şentürk, T. vd. (2010). "Serum choline levels in patients with stable angina and acute coronary syndromes: Relation to the severity of coronary artery disease". Coronary Artery Disease, 21(8), 466-471.
Abstract: Objective We sought to investigate whether serum choline levels are increased across the spectrum of coronary artery disease (CAD) manifestations and correlate with the severity of coronary stenosis. Methods A total of 36 patients with acute coronary syndrome (ACS) [22 patients with non-ST-segment elevation ACS and 14 patients with ST-segment elevation acute myocardial infarction (STEMI)], 22 patients with stable angina pectoris (SAP), and 18 controls were recruited for the study. In ACS patients, serum choline levels were measured on admission, and at 24 and 48 h thereafter, using high-performance liquid chromatography. The severity of CAD was assessed using the Gensini score. Results Serum choline levels on admission were significantly higher in the entire group of patients with ACS than in controls. The highest level of choline was observed in the STEMI group, followed by the SAP, and the non-ST-segment elevation ACS groups. Serum choline levels decreased gradually in patients with STEMI over the 48-h period. Serum choline levels on admission, and at 24 or 48 h thereafter, did not correlate with the presence of CAD neither in patients with ACS (P = 0.78, 0.98 and 0.98, respectively) nor in those with SAP (P = 0.92). Conclusion Our results suggest that serum choline levels are increased in ACS patients. However, there was no clear correlation between levels of choline and the severity and extent of CAD in this patient group. Coron Artery Dis 21:466-471
URI: https://doi.org/10.1097/MCA.0b013e32833bdf39
https://journals.lww.com/coronary-artery/Fulltext/2010/12000/Serum_choline_levels_in_patients_with_stable.5.aspx
http://hdl.handle.net/11452/27383
ISSN: 0954-6928
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.